全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 2230200-76-5 | methyl 2-(chloromethyl)-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylate | C14H15ClN2O3 |
| 2230475-63-3 | Kdm4-IN-4;(1R,2S,3R,4S)-3-[(dimethylamino)methyl]-1-phenylbicyclo[2.2.1]heptan-2-ol | C16H23NO |
| 2230697-41-1 | NRF2 activator-1;ethyl (3S)-3-(7-methoxy-1-methylbenzotriazol-5-yl)-3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1?6,2-benzoxathiazepin-2-yl]methyl]phenyl]propanoate | C30H34N4O6S |
| 2230788-58-4 | meCgPPh Pd G3;[(1,3,5,7-Tetramethyl-6-phenyl-2,4,6-trioxa-6-phosphaadamantane)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate | C29H34NO6PPdS |
| 2230788-63-1 | TrixiePhos Pd G3;Mesyl(2-(di-tert-butylphosphino)-1,1'-binaphthyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) | C41H44NO3PPdS |
| 2230788-66-4 | [4-[2-[bis(tricyclo[3.3.1.13,7]dec-1-yl)phosphino-κP]phenyl]morpholine](methanesulfonato-κO)[2'-(methylamino-κN)[1,1'-biphenyl]-2-yl-κC]-Palladium | C44H57N2O4PPdS |
| 2230788-67-5 | Mesylate[(di(1-adamantyl)-n-butylphosphine)-2-(2'-amino-1,1'-biphenyl)]palladium(II);cataCXium Pd G4 | C38H54NO3PPdS |
| 2230800-88-9 | Eltrombopag Impurity 40;methyl 3'-amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate | C14H13NO3 |
| 2230836-55-0 | N-((R)-1-(3-amino-5-(trifluoromethyl)phenyl)ethyl)-7-methoxy-2-methyl-6-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine | C26H41P |
| 2230840-12-5 | 7-methoxy-2-methyl-6-[(3S)-oxolan-3-yl]oxy-6H-quinazolin-4-one | C14H16N2O4 |
| 2230840-47-6 | (R)-1-(3-Nitro-5-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride;(1R)-1-[3-nitro-5-(trifluoromethyl)phenyl]ethanamine;hydrochloride | C9H10ClF3N2O2 |
| 2230901-24-1 | (3-Amino-2-methylphenyl)boronic acid hydrochloride | C7H10BNO2.HCl |
| 2231663-53-7 | (2R)-2-(tert-butoxycarbonylamino)-2-(3,3-difluorocyclobutyl)acetic acid | C11H17F2NO4 |
| 2231747-18-3 | N-piperidine Ibrutinib hydrochloride;3-(4-phenoxyphenyl)-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-4-amine hydrochloride | C15H26N2O6 |
| 2231764-75-1 | Mometasone EP Impurity S;6Ryw63P5NH;[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate | C27H30Cl2O6 |
| 2238831-60-0 | Datopotamab deruxtecan | |
| 2239295-71-5 | PBDB-T-2Cl;PCE14; Poly[[4,8-bis[5-(2-ethylhexyl)-4-chloro-2-thienyl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]-2,5-thiophenediyl[5,7-bis(2-ethylhexyl)-4,8-dioxo-4H,8H-benzo[1,2-c:4,5-c']dithiophene-1,3-diyl]-2,5-thiophenediyl] | (C68H76C12O2S8)n |
| 2241140-83-8 | 4-Fluoro-4-(trifluoromethyl)piperidine hydrochloride (1:1) | C6H10ClF4N |
| 2241720-34-1 | 7-Bromo-2,4-dichloro-8-fluoro-6-iodoquinazoline | C8HBrCl2FIN2 |
| 2241721-74-2 | 7-Bromo-8-fluoro-6-iodoquinazoline-2,4(1H,3H)-dione | C8H3BrFIN2O2 |
| 2242426-49-7 | 2-((Tert-butoxycarbonyl)amino)-4,4,4-trifluoro-3,3-dimethylbutanoic acid;4,4,4-trifluoro-3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid | C11H18F3NO4 |
| 2243785-97-7 | Posaconazole Enantiomer 1;4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one | C37H42F2N8O4 |
| 2244103-96-4 | Edoxaban N-oxide;N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-5-oxido-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-5-ium-2-carbonyl)amino]cyclohexyl]oxamide | C24H30ClN7O5S |
| 2244777-12-4 | Tinosporol A | C21H26O8 |
| 2244777-15-7 | Tinosporoside A | C27H36O12 |
| 2244986-82-9 | Tamsulosin EP Impurity C;DE(ethoxy)tamsulosin;2-methoxy-5-[(2R)-2-(2-phenoxyethylamino)propyl]benzenesulfonamide | C18H24N2O4S |
| 2245111-15-1 | 4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate | C5H3Cl2LiN2O3 |
| 2245238-80-4 | Lithium 4,6-Dichloropyridazine-3-carboxylate | C5HCl2LiN2O2 |
| 2245335-70-8 | (2S,3aS,6R,7aS)-3a-Methyl-2-((perfluorophenyl)thio)-6-(prop-1-en-2-yl)hexahydrobenzo[d][1,3,2]oxathiaphosphole 2-sulfide | C16H16F5OPS3 |
| 2245335-71-9 | (2R,3aR,6S,7aR)-3a-Methyl-2-((perfluorophenyl)thio)-6-(prop-1-en-2-yl)hexahydrobenzo[d][1,3,2]oxathiaphosphole 2-sulfide | C16H16F5OPS3 |
| 2246363-09-5 | 8-Chloro-7-fluoro-6-iodoisoquinolin-3-amine | C9H5ClFIN2 |
| 2246363-11-9 | (2-Chloro-3-fluoro-4-iodophenyl)methanamine | C7H6ClFIN |
| 2247372-59-2 | (2R,4R)-2-(2-chlorophenyl)-3-(4-(3,5-dimethylisoxazol-4-yl)benzoyl)thiazolidine-4-carboxylic acid | C22H19ClN2O4S |
| 2248628-93-3 | Elagolix Lactam Impurity;(R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-(2-oxopyrrolidin-1-yl)-2-phenylethyl)pyrimidine-2,4(1H,3H)-dione | C32H28F5N3O4 |
| 2250243-23-1 | Vonoprazan Fumarate Impurity 1;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-[[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]methyl]-N-methylmethanamine | C33H27F2N5O4S2 |
| 2250243-41-3 | Indacaterol Impurity 3;5-[2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-ethoxyethyl]-8-hydroxy-1H-quinolin-2-one | C26H32N2O3 |
| 2252153-95-8 | Salbutamol EP Impurity H;4-(2-(tert-Butylamino)ethyl)-2-methylphenol hydrochloride | C13H22ClNO |
| 2252237-87-7 | 1-Bromo-4-chlorodibenzo[b,d]furan | C12H6BrClO |
| 2252493-06-2 | DBCO-SH;N-[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]-3-sulfanylpropanamide | C21H20N2O2S |
| 2253964-85-9 | Linagliptin Impurity 5;7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-8-[[(3S)-piperidin-3-yl]amino]purine-2,6-dione | C25H28N8O2 |
| 2253969-12-7 | 3,9-Diamino-benzo[1,2-b:4,5-b']bis[1]benzothiophene-5,5,11,11-tetraoxide | C18H12N2O4S2 |
| 2254447-02-2 | Benzo[d][1,3]dioxole-5-carbonyl fluoride | C8H5FO3 |
| 2257421-80-8 | Progesterone EP Impurity L;20-Methylidene-3-oxopregn-4-en-21-al;2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]prop-2-enal | C22H30O2 |
| 2259708-00-2 | Sacubitril-(2R,4R)-Isomer;4-(((2R,4R)-1-([1,1'-Biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | C24H29NO5 |
| 2261008-21-1 | Naphtho[2,3-b]benzofuran-1-ylboronic acid | C16H11BO3 |
| 2269476-12-0 | 5,8-Dibromo-6,7-difluoro-2-((2-hexyldecyl)oxy)quinoxaline | C24H34Br2F2N2O |
| 2269476-13-1 | PTQ10;5,8-dibromo-6,7-difluoro-2-(2-hexyldecoxy)quinoxaline trimethyl-(5-trimethylstannylthiophen-2-yl)stannane | C34H54Br2F2N2OSSn2 |
| 2271228-51-2 | Acetamide Baricitinib Impurity;2-(3-(4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1- (ethylsulfonyl)azetidin-3-yl)acetonitrile hydrochloride | C16H19N7O3S |
| 2271228-52-3 | Baricitinib Acetic Acid Impurity;{1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidinyl}acetic acid | C16H18N6O4S |
| 2271411-87-9 | Ibandronate Impurity 3;Tetrasodium (1-hydroxy-3-(methyloxido(pentyl)azanyl)propane-1,1-diyl)bis(phosphonate) | C9H19NO8P2 .4Na |